Koers Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
Aandelen
GENIL
TREGENL00024
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
57,5 TRY | +0,26% | -0,86% | +22,65% |
Omzet 2022 | 5,45 mld. 168 mln. 156 mln. | Omzet 2023 | 8,15 mld. 251 mln. 234 mln. | Marktkapitalisatie | 14,06 mld. 433 mln. 404 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 1,08 mld. 33,24 mln. 31,01 mln. | Nettowinst (verlies) 2023 | 455 mln. 14 mln. 13,07 mln. | EV/omzet 2022 | 2,76 x |
Nettoliquiditeiten 2022 | 494 mln. 15,21 mln. 14,19 mln. | Nettoschuld 2023 | 594 mln. 18,28 mln. 17,06 mln. | EV/omzet 2023 | 1,8 x |
K/w-verhouding 2022 |
14,4
x | K/w-verhouding 2023 |
30,9
x | Werknemers | 622 |
Dividendrendement 2022 |
2,15% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 25,75% |
1 dag | +0,26% | ||
1 week | -0,86% | ||
Lopende maand | -14,05% | ||
1 maand | -16,97% | ||
3 maanden | +12,30% | ||
6 maanden | +3,05% | ||
Lopend jaar | +22,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nadir Ulu
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-23 |
Ali Ketencioglu
IRC | Investor Relations Contact | - | 01-09-21 |
Sales & Marketing | - | 01-08-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Abidin Gulmus
CHM | Chairman | - | - |
Sukru Turkmen
BRD | Director/Board Member | - | - |
Ömer Dinçer
BRD | Director/Board Member | - | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,22% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 57,5 | +0,26% | 787 715 |
24-04-24 | 57,35 | -3,21% | 1 538 479 |
22-04-24 | 59,25 | +1,11% | 1 632 512 |
19-04-24 | 58,6 | +1,03% | 922 506 |
18-04-24 | 58 | +2,65% | 2 409 236 |
uitgestelde koers Borsa Istanbul, 25 april 2024 om 17:09 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+22,65% | 529 mln. | |
+24,17% | 562 mld. | |
-6,33% | 358 mld. | |
+19,90% | 322 mld. | |
+7,95% | 297 mld. | |
+13,45% | 219 mld. | |
+6,04% | 199 mld. | |
-10,51% | 196 mld. | |
-12,26% | 149 mld. | |
-6,47% | 146 mld. |